PAR PHARM FDA Approval ANDA 088850

ANDA 088850

PAR PHARM

FDA Drug Application

Application #088850

Application Sponsors

ANDA 088850PAR PHARM

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL50MG0HYDROFLUMETHIAZIDEHYDROFLUMETHIAZIDE

FDA Submissions

ORIG1AP1985-05-31
LABELING; LabelingSUPPL3AP1988-11-14
LABELING; LabelingSUPPL4AP1991-03-11
LABELING; LabelingSUPPL5AP1991-11-22
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1996-06-07

Submissions Property Types

ORIG1Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0

CDER Filings

PAR PHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 88850
            [companyName] => PAR PHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROFLUMETHIAZIDE","activeIngredients":"HYDROFLUMETHIAZIDE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDROFLUMETHIAZIDE","submission":"HYDROFLUMETHIAZIDE","actionType":"50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.